Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease
- PMID: 7889002
Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease
Abstract
The response of IFN-gamma, IL-2 and IL-5 mRNA expression to the stimulation of concanavalin A (Con A) in peripheral blood mononuclear cells (PBMC) after bone marrow transplantation (BMT) was analyzed using reverse-transcriptase polymerase chain reaction (RT-PCR) to assess the recovery of T cell function. The subjects were 23 patients undergoing allogeneic BMT, 1 syngeneic BMT, 1 autologous BMT and 2 normal individuals. IFN-gamma mRNA expression increased after Con A stimulation in 6 patients who had limited chronic graft versus host disease (GVHD), 14 patients who did not have chronic GVHD, each one patient receiving syngeneic and autologous BMT and 2 normal individuals. On the other hand, IFN-gamma mRNA expression was not increased by Con A stimulation in 4 patients who had extensive chronic GVHD. Also, the concentration of IFN-gamma in cultured medium in a patient with extensive chronic GVHD was not detectable. A similar low response of IL-2 and IL-5 mRNA expression to Con A was observed in these patients with extensive chronic GVHD. These findings indicate that the cytokine productive capacity of T cell (IFN-gamma and IL-2 could be produced by type 1 T helper (Th1) cells and IL-5 could be produced by type 2 T helper (Th2) cells) was suppressed in patients who had extensive chronic GVHD, while that capacity was almost normal in patients without chronic GVHD and with limited chronic GVHD. Therefore, the analysis of cytokine gene response to Con A stimulation may provide useful information regarding immune reconstitution after BMT.
Similar articles
-
Cytokine expression in human cutaneous chronic graft-versus-host disease.Bone Marrow Transplant. 1996 Jun;17(6):1085-92. Bone Marrow Transplant. 1996. PMID: 8807119
-
Cytokine expression during acute graft-versus-host disease after allogeneic peripheral stem cell transplantation.Bone Marrow Transplant. 2005 Jun;35(12):1179-86. doi: 10.1038/sj.bmt.1704972. Bone Marrow Transplant. 2005. PMID: 15852028
-
Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intact.Bone Marrow Transplant. 1994 Feb;13(2):187-95. Bone Marrow Transplant. 1994. PMID: 8205088
-
Cytokines involved in graft-versus-host disease.Hokkaido Igaku Zasshi. 1994 Nov;69(6):1348-53. Hokkaido Igaku Zasshi. 1994. PMID: 7705747 Review.
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
Cited by
-
Clinical application of allogeneic peripheral blood stem cells transplantation.Ann Hematol. 1995 Dec;71(6):265-9. doi: 10.1007/BF01697977. Ann Hematol. 1995. PMID: 8534756 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical